Co-Authors
This is a "connection" page, showing publications co-authored by Nanshan Zhong and Jingyi Liang.
Connection Strength
0.335
-
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial. Phytomedicine. 2021 May; 85:153242.
Score: 0.221
-
Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trial. Pulm Circ. 2021 Jul-Sep; 11(3):20458940211032125.
Score: 0.060
-
Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. J Thorac Dis. 2020 Mar; 12(3):165-174.
Score: 0.054